SwePub
Sök i LIBRIS databas

  Extended search

L773:0167 0115
 

Search: L773:0167 0115 > (2000-2004) > A synthetic VIP pep...

A synthetic VIP peptide analogue inhibits neutrophil recruitment in rat airways in vivo

Sergejeva, Svetlana, 1972 (author)
Gothenburg University,Göteborgs universitet,Institutionen för invärtesmedicin, Avdelningen för lungmedicin och allergologi,Institute of Internal Medicine, Dept of Respiratory Medicine/Allergology
Hoshino, Hiroshi (author)
Yoshihara, S. (author)
show more...
Kashimoto, K. (author)
Lötvall, Jan, 1956 (author)
Gothenburg University,Göteborgs universitet,Institutionen för invärtesmedicin, Avdelningen för lungmedicin och allergologi,Institute of Internal Medicine, Dept of Respiratory Medicine/Allergology
Lindén, Anders, 1961 (author)
Gothenburg University,Göteborgs universitet,Institutionen för invärtesmedicin, Avdelningen för lungmedicin och allergologi,Institute of Internal Medicine, Dept of Respiratory Medicine/Allergology
show less...
 (creator_code:org_t)
Elsevier BV, 2004
2004
English.
In: Regulatory peptides. - : Elsevier BV. - 0167-0115. ; 117:2, s. 149-54
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Currently, there is no effective pharmacotherapy against exaggerated mobilisation of neutrophils in human airway diseases such as chronic obstructive pulmonary disease and asthma. We evaluated the effect of two synthetic vasoactive intestinal peptide (VIP)-like analogues on cytokine-induced neutrophil recruitment in airways in vivo. Recombinant interleukin (IL)-1 beta was administered intratracheally (i.t.) to intubated, spontaneously breathing Sprague-Dawley rats. The rats were pretreated either with a VIP synthetic peptide analogue, a pituitary adenylate cyclase-activating peptide (PACAP)-1-27 synthetic analogue, the beta(2)-adrenoceptor agonist salbutamol or vehicle, systemically or locally. Differential cell counts were performed on bronchoalveolar lavage fluid (BALf) cytospins. Effects on mean arterial blood pressure (MAP) were monitored in separate experiments. Systemic administration of the VIP analogue, the PACAP analogue and salbutamol attenuated the cytokine-induced increase in BALf neutrophil number. Local administration of the VIP analogue and salbutamol, but not the PACAP analogue, also decreased the neutrophil number in BALf. Local administration of the VIP analogue and salbutamol caused a transient decrease in MAP. Systemic or local administration of a synthetic VIP peptide analogue inhibits cytokine-induced neutrophil recruitment in airways in vivo. This action is exerted without severe, sustained cardiovascular side effects, and deserves to be further evaluated in obstructive pulmonary diseases in human.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Dermatologi och venereologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Dermatology and Venereal Diseases (hsv//eng)

Keyword

Albuterol/pharmacology
Animals
Blood Pressure/drug effects
Cytokines/antagonists & inhibitors/pharmacology
Humans
Lung/cytology/*drug effects
Male
Neuropeptides/pharmacology
Neutrophil Infiltration/*drug effects
Neutrophils/*drug effects
Pituitary Adenylate Cyclase-Activating Polypeptide
Rats
Rats
Sprague-Dawley
Vasoactive Intestinal Peptide/chemical synthesis/*pharmacology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view